Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.44B |
| 2 |
Microsoft
MSFT
|
+$556M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$433M |
| 4 |
Johnson & Johnson
JNJ
|
+$349M |
| 5 |
Amazon
AMZN
|
+$340M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$873M |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$799M |
| 3 |
Colgate-Palmolive
CL
|
+$602M |
| 4 |
Palo Alto Networks
PANW
|
+$574M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$405M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Financials | 13.96% |
| 3 | Healthcare | 12.45% |
| 4 | Miscellaneous | 11.59% |
| 5 | Consumer Discretionary | 10.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Axalta
AXTA
$7.04B
| $1.34M | ﹤0.01% |
63,684
-85,771
| -57% | -$2.11M |
|
1952
California Resources
CRC
$4.66B
| $1.34M | ﹤0.01% |
34,852
-14,933
| -30% | -$649K |
|
1953
Community Trust Bancorp
CTBI
$1.37B
| $1.34M | ﹤0.01% |
33,004
+1,913
| +6% | +$81.2K |
|
1954
RBC Bearings
RBC
$16B
| $1.34M | ﹤0.01% |
6,430
+4,998
| +349% | +$1.15M |
|
1955
Tecnoglass Holdings
TGLS
$1.57B
| $1.34M | ﹤0.01% |
63,665
+8,255
| +15% | +$180K |
|
1956
Valaris
VAL
$5.62B
| $1.34M | ﹤0.01% |
27,318
-855,298
| -97% | -$41M |
|
1957
Pembina Pipeline
PBA
$26B
| $1.33M | ﹤0.01% |
43,909
+14,594
| +50% | +$520K |
|
1958
HealthEquity
HQY
$7.3B
| $1.33M | ﹤0.01% |
19,853
+11,941
| +151% | +$756K |
|
|
TGVC
1959
DELISTED
TG Venture Acquisition Corp. Class A Common Stock
TGVC
| $1.33M | ﹤0.01% |
133,904
+19,300
| +17% | +$192K |
|
1960
Gildan
GIL
$7.59B
| $1.33M | ﹤0.01% |
47,068
+40,522
| +619% | +$1.21M |
|
1961
First Bancorp
FBP
$4.13B
| $1.33M | ﹤0.01% |
97,066
-24,769
| -20% | -$359K |
|
1962
Korn Ferry
KFY
$3.91B
| $1.32M | ﹤0.01% |
28,171
-21,762
| -44% | -$1.29M |
|
1963
Encompass Health
EHC
$12.2B
| $1.32M | ﹤0.01% |
29,243
-14,876
| -34% | -$744K |
|
1964
MINISO
MNSO
$2.58B
| $1.32M | ﹤0.01% |
240,612
+222,612
| +1,237% | +$1.37M |
|
|
LNW
1965
DELISTED
Light & Wonder
LNW
| $1.32M | ﹤0.01% |
30,773
+10,261
| +50% | +$507K |
|
|
KZR
1966
DELISTED
Kezar Life Sciences
KZR
| $1.32M | ﹤0.01% |
15,321
+14,918
| +3,702% | +$1.45M |
|
|
STSA
1967
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $1.31M | ﹤0.01% |
218,902
+16,424
| +8% | +$93.1K |
|
1968
Sonic Automotive
SAH
$2.05B
| $1.31M | ﹤0.01% |
30,298
-64,038
| -68% | -$2.9M |
|
|
SLAC
1969
DELISTED
Social Leverage Acquisition Corp I Class A Common Stock
SLAC
| $1.31M | ﹤0.01% |
133,585
+131,502
| +6,313% | +$1.29M |
|
|
GMS
1970
DELISTED
GMS Inc
GMS
| $1.31M | ﹤0.01% |
32,680
-9,650
| -23% | -$462K |
|
1971
Atara Biotherapeutics
ATRA
$88.4M
| $1.31M | ﹤0.01% |
13,825
+12,961
| +1,500% | +$1.46M |
|
|
SHAC
1972
DELISTED
SCP & CO Healthcare Acquisition Company Class A Common Stock
SHAC
| $1.3M | ﹤0.01% |
132,189
| – | – |
|
1973
Rambus
RMBS
$11.4B
| $1.3M | ﹤0.01% |
51,240
-10,749
| -17% | -$269K |
|
1974
iShares Core US Aggregate Bond ETF
AGG
$136B
| $1.3M | ﹤0.01% |
13,492
-477,180
| -97% | -$48.3M |
|
1975
JELD-WEN Holding
JELD
$160M
| $1.3M | ﹤0.01% |
148,379
+94,041
| +173% | +$1.23M |
|
Similar funds
Barclays's Q3 2022 Portfolio in Review
As of Q3 2022, Barclays held 5,400 positions worth $91.6B, down 44% from $163B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Barclays deployed $5.45B of net new capital in Q3 2022, opening 261 new positions and adding to 1,854 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $27.1M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $873M trimmed.
- Barclays's largest Q3 2022 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $27.1M.
- Barclays added most to Apple in Q3 2022, an estimated $1.44B increase.
- Barclays's biggest Q3 2022 reduction was Invesco QQQ Trust, cutting an estimated $873M.
- Barclays fully exited Vonage Holdings Corporation in Q3 2022, selling an estimated $99.4M.
- Barclays's ten largest holdings make up 22% of its $91.6B portfolio in Q3 2022.
- Barclays opened 261 new positions and closed 533 in Q3 2022.
- Barclays's portfolio value fell 44% quarter-over-quarter to $91.6B.
Based on Barclays's 13F filing for Q3 2022, filed 3 Nov 2022.